nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—BCHE—kidney cancer	0.227	0.719	CbGaD
Chlorpromazine—ABCB1—kidney cancer	0.089	0.282	CbGaD
Chlorpromazine—ABCB11—Paclitaxel—kidney cancer	0.0388	0.0907	CbGbCtD
Chlorpromazine—ABCB11—Vinblastine—kidney cancer	0.0341	0.0795	CbGbCtD
Chlorpromazine—ABCB11—Vincristine—kidney cancer	0.0335	0.0782	CbGbCtD
Chlorpromazine—HTR2B—Sorafenib—kidney cancer	0.0285	0.0667	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—kidney cancer	0.0209	0.0489	CbGbCtD
Chlorpromazine—ABCB1—Temsirolimus—kidney cancer	0.0194	0.0453	CbGbCtD
Chlorpromazine—KCNH2—Sunitinib—kidney cancer	0.0192	0.0448	CbGbCtD
Chlorpromazine—HTR2C—Sorafenib—kidney cancer	0.0186	0.0434	CbGbCtD
Chlorpromazine—CYP2D6—Temsirolimus—kidney cancer	0.0183	0.0427	CbGbCtD
Chlorpromazine—CYP3A4—Everolimus—kidney cancer	0.0172	0.0402	CbGbCtD
Chlorpromazine—ALB—Erlotinib—kidney cancer	0.0139	0.0325	CbGbCtD
Chlorpromazine—CYP1A2—Pazopanib—kidney cancer	0.0117	0.0272	CbGbCtD
Chlorpromazine—CYP3A4—Temsirolimus—kidney cancer	0.0116	0.0271	CbGbCtD
Chlorpromazine—ABCB1—Pazopanib—kidney cancer	0.0102	0.0238	CbGbCtD
Chlorpromazine—CYP2D6—Pazopanib—kidney cancer	0.0096	0.0224	CbGbCtD
Chlorpromazine—ABCB1—Dactinomycin—kidney cancer	0.00932	0.0218	CbGbCtD
Chlorpromazine—CYP1A2—Erlotinib—kidney cancer	0.00831	0.0194	CbGbCtD
Chlorpromazine—ABCB1—Gemcitabine—kidney cancer	0.00737	0.0172	CbGbCtD
Chlorpromazine—ABCB1—Erlotinib—kidney cancer	0.00727	0.017	CbGbCtD
Chlorpromazine—CYP2D6—Erlotinib—kidney cancer	0.00685	0.016	CbGbCtD
Chlorpromazine—CYP1A2—Sorafenib—kidney cancer	0.00676	0.0158	CbGbCtD
Chlorpromazine—ABCB1—Paclitaxel—kidney cancer	0.00666	0.0155	CbGbCtD
Chlorpromazine—CHRM3—ureter—kidney cancer	0.00662	0.133	CbGeAlD
Chlorpromazine—CYP3A4—Pazopanib—kidney cancer	0.0061	0.0143	CbGbCtD
Chlorpromazine—ABCB1—Sorafenib—kidney cancer	0.00591	0.0138	CbGbCtD
Chlorpromazine—ABCB1—Vinblastine—kidney cancer	0.00584	0.0136	CbGbCtD
Chlorpromazine—SMPD1—urine—kidney cancer	0.00578	0.116	CbGeAlD
Chlorpromazine—ABCB1—Vincristine—kidney cancer	0.00574	0.0134	CbGbCtD
Chlorpromazine—CYP2D6—Sorafenib—kidney cancer	0.00557	0.013	CbGbCtD
Chlorpromazine—CYP2D6—Vinblastine—kidney cancer	0.0055	0.0128	CbGbCtD
Chlorpromazine—ABCB1—Sunitinib—kidney cancer	0.00479	0.0112	CbGbCtD
Chlorpromazine—CYP3A4—Erlotinib—kidney cancer	0.00436	0.0102	CbGbCtD
Chlorpromazine—CYP3A4—Paclitaxel—kidney cancer	0.00399	0.00931	CbGbCtD
Chlorpromazine—ABCB1—Doxorubicin—kidney cancer	0.00359	0.00838	CbGbCtD
Chlorpromazine—CYP3A4—Sorafenib—kidney cancer	0.00354	0.00827	CbGbCtD
Chlorpromazine—CYP3A4—Vinblastine—kidney cancer	0.0035	0.00817	CbGbCtD
Chlorpromazine—CYP3A4—Vincristine—kidney cancer	0.00344	0.00803	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—kidney cancer	0.00338	0.00789	CbGbCtD
Chlorpromazine—CYP3A4—Sunitinib—kidney cancer	0.00287	0.0067	CbGbCtD
Chlorpromazine—CYP3A4—Doxorubicin—kidney cancer	0.00215	0.00502	CbGbCtD
Chlorpromazine—CYP1A2—urine—kidney cancer	0.00163	0.0328	CbGeAlD
Chlorpromazine—SMPD1—nephron tubule—kidney cancer	0.00156	0.0312	CbGeAlD
Chlorpromazine—CYP2E1—urine—kidney cancer	0.00147	0.0295	CbGeAlD
Chlorpromazine—SMPD1—renal system—kidney cancer	0.00141	0.0284	CbGeAlD
Chlorpromazine—SMPD1—kidney—kidney cancer	0.00137	0.0275	CbGeAlD
Chlorpromazine—SMPD1—cortex of kidney—kidney cancer	0.00133	0.0267	CbGeAlD
Chlorpromazine—HTR2A—urine—kidney cancer	0.00128	0.0256	CbGeAlD
Chlorpromazine—SMPD1—gonad—kidney cancer	0.00127	0.0255	CbGeAlD
Chlorpromazine—SMPD1—cardiac atrium—kidney cancer	0.00127	0.0254	CbGeAlD
Chlorpromazine—CYP3A4—urine—kidney cancer	0.00118	0.0237	CbGeAlD
Chlorpromazine—CYP2D6—urine—kidney cancer	0.00116	0.0234	CbGeAlD
Chlorpromazine—ADRA1B—renal system—kidney cancer	0.00086	0.0173	CbGeAlD
Chlorpromazine—ADRA1B—kidney—kidney cancer	0.000831	0.0167	CbGeAlD
Chlorpromazine—CALM3—nephron tubule—kidney cancer	0.000721	0.0145	CbGeAlD
Chlorpromazine—Dimetacrine—ACHE—kidney cancer	0.000679	0.343	CrCbGaD
Chlorpromazine—SLC22A1—renal system—kidney cancer	0.000634	0.0127	CbGeAlD
Chlorpromazine—CALM3—cortex of kidney—kidney cancer	0.000617	0.0124	CbGeAlD
Chlorpromazine—SLC22A1—kidney—kidney cancer	0.000613	0.0123	CbGeAlD
Chlorpromazine—CALM3—cardiac atrium—kidney cancer	0.000587	0.0118	CbGeAlD
Chlorpromazine—CALM2—nephron tubule—kidney cancer	0.000566	0.0114	CbGeAlD
Chlorpromazine—CALM1—nephron tubule—kidney cancer	0.000564	0.0113	CbGeAlD
Chlorpromazine—HTR2B—cortex of kidney—kidney cancer	0.000551	0.0111	CbGeAlD
Chlorpromazine—CHRM3—renal system—kidney cancer	0.000526	0.0106	CbGeAlD
Chlorpromazine—HTR1A—renal system—kidney cancer	0.000524	0.0105	CbGeAlD
Chlorpromazine—CALM2—renal system—kidney cancer	0.000515	0.0103	CbGeAlD
Chlorpromazine—CALM1—renal system—kidney cancer	0.000513	0.0103	CbGeAlD
Chlorpromazine—CHRM3—kidney—kidney cancer	0.000509	0.0102	CbGeAlD
Chlorpromazine—HTR7—renal system—kidney cancer	0.000501	0.0101	CbGeAlD
Chlorpromazine—CALM2—kidney—kidney cancer	0.000498	0.01	CbGeAlD
Chlorpromazine—CALM1—kidney—kidney cancer	0.000495	0.00995	CbGeAlD
Chlorpromazine—CALM2—cortex of kidney—kidney cancer	0.000485	0.00974	CbGeAlD
Chlorpromazine—HTR7—kidney—kidney cancer	0.000484	0.00972	CbGeAlD
Chlorpromazine—ADRA1A—renal system—kidney cancer	0.000483	0.0097	CbGeAlD
Chlorpromazine—CALM1—cortex of kidney—kidney cancer	0.000483	0.00969	CbGeAlD
Chlorpromazine—BCHE—nephron tubule—kidney cancer	0.000472	0.00949	CbGeAlD
Chlorpromazine—KCNH2—renal system—kidney cancer	0.000466	0.00937	CbGeAlD
Chlorpromazine—CALM2—gonad—kidney cancer	0.000462	0.00928	CbGeAlD
Chlorpromazine—CALM2—cardiac atrium—kidney cancer	0.000461	0.00926	CbGeAlD
Chlorpromazine—CALM1—gonad—kidney cancer	0.00046	0.00923	CbGeAlD
Chlorpromazine—CALM1—cardiac atrium—kidney cancer	0.000459	0.00922	CbGeAlD
Chlorpromazine—HTR7—gonad—kidney cancer	0.000449	0.00902	CbGeAlD
Chlorpromazine—KCNH2—cardiac atrium—kidney cancer	0.000418	0.00839	CbGeAlD
Chlorpromazine—CYP1A2—renal system—kidney cancer	0.000399	0.00802	CbGeAlD
Chlorpromazine—CYP2E1—nephron tubule—kidney cancer	0.000395	0.00794	CbGeAlD
Chlorpromazine—BCHE—cardiac atrium—kidney cancer	0.000384	0.00772	CbGeAlD
Chlorpromazine—Angioedema—Temsirolimus—kidney cancer	0.000384	0.00387	CcSEcCtD
Chlorpromazine—Muscle spasms—Pazopanib—kidney cancer	0.000381	0.00384	CcSEcCtD
Chlorpromazine—Leukopenia—Temsirolimus—kidney cancer	0.000376	0.0038	CcSEcCtD
Chlorpromazine—Agranulocytosis—Vinblastine—kidney cancer	0.000375	0.00378	CcSEcCtD
Chlorpromazine—Dysphagia—Sunitinib—kidney cancer	0.000375	0.00378	CcSEcCtD
Chlorpromazine—Cough—Temsirolimus—kidney cancer	0.000367	0.0037	CcSEcCtD
Chlorpromazine—Convulsion—Temsirolimus—kidney cancer	0.000364	0.00367	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Capecitabine—kidney cancer	0.000362	0.00365	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.000359	0.00363	CcSEcCtD
Chlorpromazine—CYP2E1—renal system—kidney cancer	0.000359	0.00722	CbGeAlD
Chlorpromazine—Erectile dysfunction—Sorafenib—kidney cancer	0.000359	0.00362	CcSEcCtD
Chlorpromazine—Pancytopenia—Sunitinib—kidney cancer	0.000356	0.00359	CcSEcCtD
Chlorpromazine—Syncope—Pazopanib—kidney cancer	0.000355	0.00358	CcSEcCtD
Chlorpromazine—Dysphagia—Dactinomycin—kidney cancer	0.000355	0.00358	CcSEcCtD
Chlorpromazine—Leukopenia—Pazopanib—kidney cancer	0.000354	0.00358	CcSEcCtD
Chlorpromazine—Oedema peripheral—Everolimus—kidney cancer	0.000354	0.00357	CcSEcCtD
Chlorpromazine—Urinary retention—Vincristine—kidney cancer	0.000349	0.00352	CcSEcCtD
Chlorpromazine—Cardiac arrest—Vincristine—kidney cancer	0.000349	0.00352	CcSEcCtD
Chlorpromazine—Loss of consciousness—Pazopanib—kidney cancer	0.000348	0.00351	CcSEcCtD
Chlorpromazine—CYP2E1—kidney—kidney cancer	0.000347	0.00698	CbGeAlD
Chlorpromazine—ADRA2A—cortex of kidney—kidney cancer	0.000346	0.00695	CbGeAlD
Chlorpromazine—Cough—Pazopanib—kidney cancer	0.000345	0.00349	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Temsirolimus—kidney cancer	0.000343	0.00346	CcSEcCtD
Chlorpromazine—Infection—Temsirolimus—kidney cancer	0.000341	0.00344	CcSEcCtD
Chlorpromazine—Jaundice—Sorafenib—kidney cancer	0.000338	0.00342	CcSEcCtD
Chlorpromazine—CYP2E1—cortex of kidney—kidney cancer	0.000338	0.00679	CbGeAlD
Chlorpromazine—Hyperglycaemia—Sunitinib—kidney cancer	0.000338	0.00341	CcSEcCtD
Chlorpromazine—Gait disturbance—Capecitabine—kidney cancer	0.000337	0.0034	CcSEcCtD
Chlorpromazine—Pancytopenia—Dactinomycin—kidney cancer	0.000337	0.0034	CcSEcCtD
Chlorpromazine—Dry mouth—Pazopanib—kidney cancer	0.00033	0.00333	CcSEcCtD
Chlorpromazine—ADRA2A—gonad—kidney cancer	0.000329	0.00661	CbGeAlD
Chlorpromazine—ADRA2A—cardiac atrium—kidney cancer	0.000329	0.00661	CbGeAlD
Chlorpromazine—Infection—Pazopanib—kidney cancer	0.000321	0.00324	CcSEcCtD
Chlorpromazine—Nasal congestion—Paclitaxel—kidney cancer	0.00032	0.00323	CcSEcCtD
Chlorpromazine—Shock—Pazopanib—kidney cancer	0.000318	0.00321	CcSEcCtD
Chlorpromazine—HTR2A—renal system—kidney cancer	0.000312	0.00627	CbGeAlD
Chlorpromazine—Insomnia—Temsirolimus—kidney cancer	0.00031	0.00313	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.000309	0.00311	CcSEcCtD
Chlorpromazine—Dyspnoea—Temsirolimus—kidney cancer	0.000306	0.00309	CcSEcCtD
Chlorpromazine—Somnolence—Temsirolimus—kidney cancer	0.000305	0.00308	CcSEcCtD
Chlorpromazine—HTR2A—kidney—kidney cancer	0.000302	0.00606	CbGeAlD
Chlorpromazine—Pancytopenia—Vincristine—kidney cancer	0.000301	0.00304	CcSEcCtD
Chlorpromazine—Influenza—Gemcitabine—kidney cancer	0.000301	0.00303	CcSEcCtD
Chlorpromazine—Muscle spasms—Everolimus—kidney cancer	0.000301	0.00303	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Paclitaxel—kidney cancer	0.000298	0.00301	CcSEcCtD
Chlorpromazine—Oedema peripheral—Sunitinib—kidney cancer	0.000295	0.00298	CcSEcCtD
Chlorpromazine—Agranulocytosis—Dactinomycin—kidney cancer	0.000295	0.00298	CcSEcCtD
Chlorpromazine—Constipation—Temsirolimus—kidney cancer	0.000293	0.00296	CcSEcCtD
Chlorpromazine—Tremor—Everolimus—kidney cancer	0.000293	0.00296	CcSEcCtD
Chlorpromazine—Insomnia—Pazopanib—kidney cancer	0.000292	0.00295	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Vincristine—kidney cancer	0.000292	0.00295	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Vincristine—kidney cancer	0.000289	0.00292	CcSEcCtD
Chlorpromazine—CYP3A4—renal system—kidney cancer	0.000289	0.00581	CbGeAlD
Chlorpromazine—Dyspnoea—Pazopanib—kidney cancer	0.000288	0.00291	CcSEcCtD
Chlorpromazine—Somnolence—Pazopanib—kidney cancer	0.000287	0.0029	CcSEcCtD
Chlorpromazine—Angioedema—Everolimus—kidney cancer	0.000286	0.00288	CcSEcCtD
Chlorpromazine—Pancytopenia—Gemcitabine—kidney cancer	0.000286	0.00288	CcSEcCtD
Chlorpromazine—CYP2D6—renal system—kidney cancer	0.000284	0.00571	CbGeAlD
Chlorpromazine—Leukopenia—Vinblastine—kidney cancer	0.000281	0.00283	CcSEcCtD
Chlorpromazine—Syncope—Everolimus—kidney cancer	0.00028	0.00283	CcSEcCtD
Chlorpromazine—HTR2A—gonad—kidney cancer	0.00028	0.00562	CbGeAlD
Chlorpromazine—Leukopenia—Everolimus—kidney cancer	0.00028	0.00282	CcSEcCtD
Chlorpromazine—CYP3A4—kidney—kidney cancer	0.000279	0.00561	CbGeAlD
Chlorpromazine—Cardiac arrest—Paclitaxel—kidney cancer	0.000277	0.00279	CcSEcCtD
Chlorpromazine—CYP2D6—kidney—kidney cancer	0.000275	0.00552	CbGeAlD
Chlorpromazine—Loss of consciousness—Everolimus—kidney cancer	0.000275	0.00277	CcSEcCtD
Chlorpromazine—Cough—Everolimus—kidney cancer	0.000273	0.00275	CcSEcCtD
Chlorpromazine—Photosensitivity—Capecitabine—kidney cancer	0.000272	0.00275	CcSEcCtD
Chlorpromazine—Convulsion—Vinblastine—kidney cancer	0.000272	0.00274	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Gemcitabine—kidney cancer	0.000271	0.00274	CcSEcCtD
Chlorpromazine—Body temperature increased—Temsirolimus—kidney cancer	0.000271	0.00274	CcSEcCtD
Chlorpromazine—Convulsion—Everolimus—kidney cancer	0.000271	0.00273	CcSEcCtD
Chlorpromazine—Syncope—Erlotinib—kidney cancer	0.00027	0.00273	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Paclitaxel—kidney cancer	0.000266	0.00268	CcSEcCtD
Chlorpromazine—Loss of consciousness—Erlotinib—kidney cancer	0.000265	0.00268	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Capecitabine—kidney cancer	0.000265	0.00267	CcSEcCtD
Chlorpromazine—Cough—Erlotinib—kidney cancer	0.000263	0.00266	CcSEcCtD
Chlorpromazine—Glycosuria—Doxorubicin—kidney cancer	0.000262	0.00264	CcSEcCtD
Chlorpromazine—Muscle spasms—Sorafenib—kidney cancer	0.000261	0.00263	CcSEcCtD
Chlorpromazine—Dry mouth—Everolimus—kidney cancer	0.00026	0.00263	CcSEcCtD
Chlorpromazine—Blood disorder—Doxorubicin—kidney cancer	0.000254	0.00256	CcSEcCtD
Chlorpromazine—Infection—Everolimus—kidney cancer	0.000253	0.00256	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000253	0.00256	CcSEcCtD
Chlorpromazine—Hypersensitivity—Temsirolimus—kidney cancer	0.000253	0.00255	CcSEcCtD
Chlorpromazine—Dysphagia—Paclitaxel—kidney cancer	0.000252	0.00254	CcSEcCtD
Chlorpromazine—Influenza—Paclitaxel—kidney cancer	0.000252	0.00254	CcSEcCtD
Chlorpromazine—Muscle spasms—Sunitinib—kidney cancer	0.000251	0.00253	CcSEcCtD
Chlorpromazine—Shock—Everolimus—kidney cancer	0.000251	0.00253	CcSEcCtD
Chlorpromazine—Agranulocytosis—Gemcitabine—kidney cancer	0.00025	0.00252	CcSEcCtD
Chlorpromazine—Tachycardia—Everolimus—kidney cancer	0.000249	0.00251	CcSEcCtD
Chlorpromazine—Angioedema—Sorafenib—kidney cancer	0.000248	0.0025	CcSEcCtD
Chlorpromazine—Infection—Erlotinib—kidney cancer	0.000245	0.00247	CcSEcCtD
Chlorpromazine—Syncope—Sorafenib—kidney cancer	0.000243	0.00246	CcSEcCtD
Chlorpromazine—Leukopenia—Sorafenib—kidney cancer	0.000243	0.00245	CcSEcCtD
Chlorpromazine—Shock—Erlotinib—kidney cancer	0.000242	0.00244	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—kidney cancer	0.000242	0.00244	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—kidney cancer	0.000242	0.00244	CcSEcCtD
Chlorpromazine—Pancytopenia—Paclitaxel—kidney cancer	0.000239	0.00241	CcSEcCtD
Chlorpromazine—Angioedema—Sunitinib—kidney cancer	0.000239	0.00241	CcSEcCtD
Chlorpromazine—Loss of consciousness—Sorafenib—kidney cancer	0.000238	0.00241	CcSEcCtD
Chlorpromazine—Hypotension—Everolimus—kidney cancer	0.000238	0.00241	CcSEcCtD
Chlorpromazine—Ethopropazine—BCHE—kidney cancer	0.000237	0.12	CrCbGaD
Chlorpromazine—Oedema peripheral—Gemcitabine—kidney cancer	0.000237	0.00239	CcSEcCtD
Chlorpromazine—Cough—Sorafenib—kidney cancer	0.000237	0.00239	CcSEcCtD
Chlorpromazine—Leukopenia—Sunitinib—kidney cancer	0.000234	0.00236	CcSEcCtD
Chlorpromazine—Insomnia—Everolimus—kidney cancer	0.000231	0.00233	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00023	0.00232	CcSEcCtD
Chlorpromazine—Cough—Sunitinib—kidney cancer	0.000228	0.0023	CcSEcCtD
Chlorpromazine—Dyspnoea—Everolimus—kidney cancer	0.000227	0.0023	CcSEcCtD
Chlorpromazine—Urinary retention—Capecitabine—kidney cancer	0.000227	0.00229	CcSEcCtD
Chlorpromazine—Cardiac arrest—Capecitabine—kidney cancer	0.000227	0.00229	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Paclitaxel—kidney cancer	0.000227	0.00229	CcSEcCtD
Chlorpromazine—Somnolence—Everolimus—kidney cancer	0.000227	0.00229	CcSEcCtD
Chlorpromazine—Dizziness—Temsirolimus—kidney cancer	0.000227	0.00229	CcSEcCtD
Chlorpromazine—Convulsion—Sunitinib—kidney cancer	0.000226	0.00228	CcSEcCtD
Chlorpromazine—Dry mouth—Sorafenib—kidney cancer	0.000226	0.00228	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—kidney cancer	0.000226	0.00228	CcSEcCtD
Chlorpromazine—ABCB1—nephron tubule—kidney cancer	0.000225	0.00452	CbGeAlD
Chlorpromazine—Insomnia—Erlotinib—kidney cancer	0.000223	0.00225	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000221	0.00223	CcSEcCtD
Chlorpromazine—Leukopenia—Dactinomycin—kidney cancer	0.000221	0.00223	CcSEcCtD
Chlorpromazine—Infection—Sorafenib—kidney cancer	0.00022	0.00222	CcSEcCtD
Chlorpromazine—Dyspnoea—Erlotinib—kidney cancer	0.000219	0.00221	CcSEcCtD
Chlorpromazine—Constipation—Vinblastine—kidney cancer	0.000219	0.00221	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Capecitabine—kidney cancer	0.000218	0.0022	CcSEcCtD
Chlorpromazine—Constipation—Everolimus—kidney cancer	0.000218	0.0022	CcSEcCtD
Chlorpromazine—Shock—Sorafenib—kidney cancer	0.000218	0.0022	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—kidney cancer	0.000217	0.00219	CcSEcCtD
Chlorpromazine—Dry mouth—Sunitinib—kidney cancer	0.000217	0.00219	CcSEcCtD
Chlorpromazine—Dizziness—Pazopanib—kidney cancer	0.000214	0.00216	CcSEcCtD
Chlorpromazine—Infection—Sunitinib—kidney cancer	0.000212	0.00214	CcSEcCtD
Chlorpromazine—Constipation—Erlotinib—kidney cancer	0.00021	0.00212	CcSEcCtD
Chlorpromazine—Dermatitis contact—Doxorubicin—kidney cancer	0.00021	0.00212	CcSEcCtD
Chlorpromazine—Shock—Sunitinib—kidney cancer	0.00021	0.00212	CcSEcCtD
Chlorpromazine—Asthma—Capecitabine—kidney cancer	0.000207	0.00208	CcSEcCtD
Chlorpromazine—Dysphagia—Capecitabine—kidney cancer	0.000207	0.00208	CcSEcCtD
Chlorpromazine—Influenza—Capecitabine—kidney cancer	0.000207	0.00208	CcSEcCtD
Chlorpromazine—ABCB1—renal system—kidney cancer	0.000205	0.00411	CbGeAlD
Chlorpromazine—Body temperature increased—Everolimus—kidney cancer	0.000202	0.00204	CcSEcCtD
Chlorpromazine—Infection—Dactinomycin—kidney cancer	0.0002	0.00202	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—kidney cancer	0.000199	0.00201	CcSEcCtD
Chlorpromazine—Clomipramine—GSTP1—kidney cancer	0.000199	0.101	CrCbGaD
Chlorpromazine—Oedema peripheral—Paclitaxel—kidney cancer	0.000198	0.002	CcSEcCtD
Chlorpromazine—ABCB1—kidney—kidney cancer	0.000198	0.00397	CbGeAlD
Chlorpromazine—Leukopenia—Vincristine—kidney cancer	0.000198	0.00199	CcSEcCtD
Chlorpromazine—Dyspnoea—Sorafenib—kidney cancer	0.000197	0.00199	CcSEcCtD
Chlorpromazine—Pancytopenia—Capecitabine—kidney cancer	0.000196	0.00198	CcSEcCtD
Chlorpromazine—Body temperature increased—Erlotinib—kidney cancer	0.000195	0.00196	CcSEcCtD
Chlorpromazine—Triflupromazine—BCHE—kidney cancer	0.000194	0.0983	CrCbGaD
Chlorpromazine—Visual impairment—Paclitaxel—kidney cancer	0.000194	0.00196	CcSEcCtD
Chlorpromazine—Insomnia—Sunitinib—kidney cancer	0.000193	0.00194	CcSEcCtD
Chlorpromazine—ABCB1—cortex of kidney—kidney cancer	0.000193	0.00387	CbGeAlD
Chlorpromazine—Convulsion—Vincristine—kidney cancer	0.000191	0.00193	CcSEcCtD
Chlorpromazine—Dyspnoea—Sunitinib—kidney cancer	0.00019	0.00192	CcSEcCtD
Chlorpromazine—Constipation—Sorafenib—kidney cancer	0.000189	0.00191	CcSEcCtD
Chlorpromazine—Hypersensitivity—Vinblastine—kidney cancer	0.000189	0.0019	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000189	0.0019	CcSEcCtD
Chlorpromazine—Hypersensitivity—Everolimus—kidney cancer	0.000188	0.0019	CcSEcCtD
Chlorpromazine—Leukopenia—Gemcitabine—kidney cancer	0.000188	0.00189	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Capecitabine—kidney cancer	0.000186	0.00188	CcSEcCtD
Chlorpromazine—ABCB1—gonad—kidney cancer	0.000183	0.00369	CbGeAlD
Chlorpromazine—Cough—Gemcitabine—kidney cancer	0.000183	0.00184	CcSEcCtD
Chlorpromazine—Constipation—Sunitinib—kidney cancer	0.000182	0.00184	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Vincristine—kidney cancer	0.00018	0.00182	CcSEcCtD
Chlorpromazine—Jaundice—Capecitabine—kidney cancer	0.00018	0.00181	CcSEcCtD
Chlorpromazine—Infection—Vincristine—kidney cancer	0.000179	0.00181	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—kidney cancer	0.000175	0.00177	CcSEcCtD
Chlorpromazine—Body temperature increased—Sorafenib—kidney cancer	0.000175	0.00177	CcSEcCtD
Chlorpromazine—Agranulocytosis—Capecitabine—kidney cancer	0.000172	0.00173	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000171	0.00173	CcSEcCtD
Chlorpromazine—Nervousness—Paclitaxel—kidney cancer	0.00017	0.00172	CcSEcCtD
Chlorpromazine—Infection—Gemcitabine—kidney cancer	0.00017	0.00171	CcSEcCtD
Chlorpromazine—Dizziness—Vinblastine—kidney cancer	0.000169	0.00171	CcSEcCtD
Chlorpromazine—Dizziness—Everolimus—kidney cancer	0.000169	0.0017	CcSEcCtD
Chlorpromazine—Muscle spasms—Paclitaxel—kidney cancer	0.000169	0.0017	CcSEcCtD
Chlorpromazine—Body temperature increased—Sunitinib—kidney cancer	0.000168	0.0017	CcSEcCtD
Chlorpromazine—Hypotension—Vincristine—kidney cancer	0.000168	0.0017	CcSEcCtD
Chlorpromazine—Tremor—Paclitaxel—kidney cancer	0.000164	0.00166	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000163	0.00165	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sorafenib—kidney cancer	0.000163	0.00165	CcSEcCtD
Chlorpromazine—Insomnia—Vincristine—kidney cancer	0.000163	0.00165	CcSEcCtD
Chlorpromazine—Oedema peripheral—Capecitabine—kidney cancer	0.000163	0.00164	CcSEcCtD
Chlorpromazine—Dizziness—Erlotinib—kidney cancer	0.000163	0.00164	CcSEcCtD
Chlorpromazine—Angioedema—Paclitaxel—kidney cancer	0.00016	0.00162	CcSEcCtD
Chlorpromazine—Hypotension—Gemcitabine—kidney cancer	0.00016	0.00161	CcSEcCtD
Chlorpromazine—Body temperature increased—Dactinomycin—kidney cancer	0.000159	0.00161	CcSEcCtD
Chlorpromazine—Visual impairment—Capecitabine—kidney cancer	0.000159	0.00161	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000159	0.00161	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000158	0.00159	CcSEcCtD
Chlorpromazine—Syncope—Paclitaxel—kidney cancer	0.000157	0.00159	CcSEcCtD
Chlorpromazine—Leukopenia—Paclitaxel—kidney cancer	0.000157	0.00158	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sunitinib—kidney cancer	0.000157	0.00158	CcSEcCtD
Chlorpromazine—Insomnia—Gemcitabine—kidney cancer	0.000155	0.00156	CcSEcCtD
Chlorpromazine—Loss of consciousness—Paclitaxel—kidney cancer	0.000154	0.00156	CcSEcCtD
Chlorpromazine—Constipation—Vincristine—kidney cancer	0.000154	0.00156	CcSEcCtD
Chlorpromazine—Cough—Paclitaxel—kidney cancer	0.000153	0.00154	CcSEcCtD
Chlorpromazine—Dyspnoea—Gemcitabine—kidney cancer	0.000152	0.00154	CcSEcCtD
Chlorpromazine—Somnolence—Gemcitabine—kidney cancer	0.000152	0.00153	CcSEcCtD
Chlorpromazine—Convulsion—Paclitaxel—kidney cancer	0.000152	0.00153	CcSEcCtD
Chlorpromazine—Hypersensitivity—Dactinomycin—kidney cancer	0.000149	0.0015	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—kidney cancer	0.000147	0.00148	CcSEcCtD
Chlorpromazine—Dizziness—Sorafenib—kidney cancer	0.000146	0.00148	CcSEcCtD
Chlorpromazine—Constipation—Gemcitabine—kidney cancer	0.000146	0.00148	CcSEcCtD
Chlorpromazine—Dry mouth—Paclitaxel—kidney cancer	0.000146	0.00147	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000143	0.00144	CcSEcCtD
Chlorpromazine—Body temperature increased—Vincristine—kidney cancer	0.000142	0.00144	CcSEcCtD
Chlorpromazine—Infection—Paclitaxel—kidney cancer	0.000142	0.00144	CcSEcCtD
Chlorpromazine—Dizziness—Sunitinib—kidney cancer	0.000141	0.00142	CcSEcCtD
Chlorpromazine—Shock—Paclitaxel—kidney cancer	0.000141	0.00142	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000141	0.00142	CcSEcCtD
Chlorpromazine—Tachycardia—Paclitaxel—kidney cancer	0.00014	0.00141	CcSEcCtD
Chlorpromazine—Muscle spasms—Capecitabine—kidney cancer	0.000138	0.0014	CcSEcCtD
Chlorpromazine—Body temperature increased—Gemcitabine—kidney cancer	0.000135	0.00136	CcSEcCtD
Chlorpromazine—Tremor—Capecitabine—kidney cancer	0.000135	0.00136	CcSEcCtD
Chlorpromazine—Hypotension—Paclitaxel—kidney cancer	0.000134	0.00135	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—kidney cancer	0.000133	0.00134	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—kidney cancer	0.000133	0.00134	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—kidney cancer	0.000133	0.00134	CcSEcCtD
Chlorpromazine—Hypersensitivity—Vincristine—kidney cancer	0.000133	0.00134	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—kidney cancer	0.000132	0.00133	CcSEcCtD
Chlorpromazine—Insomnia—Paclitaxel—kidney cancer	0.000129	0.00131	CcSEcCtD
Chlorpromazine—Syncope—Capecitabine—kidney cancer	0.000129	0.0013	CcSEcCtD
Chlorpromazine—Leukopenia—Capecitabine—kidney cancer	0.000129	0.0013	CcSEcCtD
Chlorpromazine—Dyspnoea—Paclitaxel—kidney cancer	0.000128	0.00129	CcSEcCtD
Chlorpromazine—Somnolence—Paclitaxel—kidney cancer	0.000127	0.00128	CcSEcCtD
Chlorpromazine—Loss of consciousness—Capecitabine—kidney cancer	0.000127	0.00128	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—kidney cancer	0.000126	0.00128	CcSEcCtD
Chlorpromazine—Cough—Capecitabine—kidney cancer	0.000126	0.00127	CcSEcCtD
Chlorpromazine—Constipation—Paclitaxel—kidney cancer	0.000122	0.00124	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000122	0.00123	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—kidney cancer	0.00012	0.00121	CcSEcCtD
Chlorpromazine—Dry mouth—Capecitabine—kidney cancer	0.00012	0.00121	CcSEcCtD
Chlorpromazine—Dizziness—Vincristine—kidney cancer	0.000119	0.0012	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—kidney cancer	0.000119	0.0012	CcSEcCtD
Chlorpromazine—Infection—Capecitabine—kidney cancer	0.000117	0.00118	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—kidney cancer	0.000116	0.00117	CcSEcCtD
Chlorpromazine—Shock—Capecitabine—kidney cancer	0.000116	0.00117	CcSEcCtD
Chlorpromazine—Tachycardia—Capecitabine—kidney cancer	0.000115	0.00116	CcSEcCtD
Chlorpromazine—Body temperature increased—Paclitaxel—kidney cancer	0.000113	0.00114	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000111	0.00112	CcSEcCtD
Chlorpromazine—Hypotension—Capecitabine—kidney cancer	0.00011	0.00111	CcSEcCtD
Chlorpromazine—Insomnia—Capecitabine—kidney cancer	0.000106	0.00107	CcSEcCtD
Chlorpromazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000105	0.00106	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—kidney cancer	0.000105	0.00106	CcSEcCtD
Chlorpromazine—Dyspnoea—Capecitabine—kidney cancer	0.000105	0.00106	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—kidney cancer	0.000103	0.00104	CcSEcCtD
Chlorpromazine—Constipation—Capecitabine—kidney cancer	0.0001	0.00101	CcSEcCtD
Chlorpromazine—Dizziness—Paclitaxel—kidney cancer	9.47e-05	0.000955	CcSEcCtD
Chlorpromazine—Body temperature increased—Capecitabine—kidney cancer	9.29e-05	0.000937	CcSEcCtD
Chlorpromazine—Nervousness—Doxorubicin—kidney cancer	9.01e-05	0.000909	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—kidney cancer	8.92e-05	0.0009	CcSEcCtD
Chlorpromazine—Hypersensitivity—Capecitabine—kidney cancer	8.66e-05	0.000873	CcSEcCtD
Chlorpromazine—Diltiazem—ABCB1—kidney cancer	8.54e-05	0.0432	CrCbGaD
Chlorpromazine—Syncope—Doxorubicin—kidney cancer	8.32e-05	0.00084	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—kidney cancer	8.31e-05	0.000838	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—kidney cancer	8.16e-05	0.000823	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—kidney cancer	8.1e-05	0.000817	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—kidney cancer	8.04e-05	0.000811	CcSEcCtD
Chlorpromazine—Dizziness—Capecitabine—kidney cancer	7.77e-05	0.000784	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—kidney cancer	7.73e-05	0.00078	CcSEcCtD
Chlorpromazine—Triflupromazine—ABCB1—kidney cancer	7.61e-05	0.0385	CrCbGaD
Chlorpromazine—Anaphylactic shock—Doxorubicin—kidney cancer	7.57e-05	0.000764	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—kidney cancer	7.52e-05	0.000759	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—kidney cancer	7.45e-05	0.000752	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—kidney cancer	7.39e-05	0.000746	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—kidney cancer	7.08e-05	0.000714	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—kidney cancer	6.85e-05	0.000691	CcSEcCtD
Chlorpromazine—Clobazam—ABCB1—kidney cancer	6.77e-05	0.0343	CrCbGaD
Chlorpromazine—Dyspnoea—Doxorubicin—kidney cancer	6.75e-05	0.000681	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—kidney cancer	6.73e-05	0.000679	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—kidney cancer	6.48e-05	0.000653	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—kidney cancer	5.99e-05	0.000604	CcSEcCtD
Chlorpromazine—Fluphenazine—ABCB1—kidney cancer	5.85e-05	0.0296	CrCbGaD
Chlorpromazine—Hypersensitivity—Doxorubicin—kidney cancer	5.58e-05	0.000563	CcSEcCtD
Chlorpromazine—Clomipramine—ABCB1—kidney cancer	5.35e-05	0.0271	CrCbGaD
Chlorpromazine—Chlorprothixene—ABCB1—kidney cancer	5.33e-05	0.027	CrCbGaD
Chlorpromazine—Dizziness—Doxorubicin—kidney cancer	5.01e-05	0.000505	CcSEcCtD
Chlorpromazine—Flurazepam—ABCB1—kidney cancer	4.98e-05	0.0252	CrCbGaD
Chlorpromazine—Trimipramine—ABCB1—kidney cancer	4.93e-05	0.0249	CrCbGaD
Chlorpromazine—Promethazine—ABCB1—kidney cancer	4.74e-05	0.024	CrCbGaD
Chlorpromazine—Trifluoperazine—ABCB1—kidney cancer	4.68e-05	0.0237	CrCbGaD
Chlorpromazine—Desipramine—ABCB1—kidney cancer	4.31e-05	0.0218	CrCbGaD
Chlorpromazine—Imipramine—ABCB1—kidney cancer	3.65e-05	0.0185	CrCbGaD
Chlorpromazine—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.11e-06	2.01e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—kidney cancer	2.1e-06	2e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.1e-06	2e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.1e-06	2e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—kidney cancer	2.1e-06	2e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL2—kidney cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—MAPK3—kidney cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—MAPK3—kidney cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL2—kidney cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL2—kidney cancer	2.08e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	2.07e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL2—kidney cancer	2.07e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCND1—kidney cancer	2.07e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.07e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—JUN—kidney cancer	2.07e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.06e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—MAPK1—kidney cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—KRAS—kidney cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—KRAS—kidney cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL2—kidney cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.05e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.05e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.04e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—JUN—kidney cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCND1—kidney cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—KRAS—kidney cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—JUN—kidney cancer	2.03e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.03e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—JUN—kidney cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—JUN—kidney cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.01e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—kidney cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KRAS—kidney cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—POMC—kidney cancer	2e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCND1—kidney cancer	2e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PTEN—kidney cancer	2e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—JUN—kidney cancer	2e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	1.99e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MAPK3—kidney cancer	1.99e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—JUN—kidney cancer	1.99e-06	1.9e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—MAPK1—kidney cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—MAPK1—kidney cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	1.98e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTEN—kidney cancer	1.97e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTEN—kidney cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTEN—kidney cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTEN—kidney cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTEN—kidney cancer	1.95e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTEN—kidney cancer	1.95e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	1.95e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	1.94e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	1.94e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KRAS—kidney cancer	1.94e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MYC—kidney cancer	1.94e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—kidney cancer	1.94e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	1.93e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—RAF1—kidney cancer	1.93e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MAPK3—kidney cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MAPK3—kidney cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—RELA—kidney cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—kidney cancer	1.92e-06	1.83e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB2—kidney cancer	1.91e-06	1.83e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.91e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL2—kidney cancer	1.9e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MAPK1—kidney cancer	1.89e-06	1.81e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MYC—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MTOR—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTEN—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTEN—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	1.89e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MYC—kidney cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KRAS—kidney cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KRAS—kidney cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MYC—kidney cancer	1.87e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MYC—kidney cancer	1.87e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—RAF1—kidney cancer	1.87e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—RAF1—kidney cancer	1.87e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.87e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	1.87e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—RELA—kidney cancer	1.86e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—RELA—kidney cancer	1.86e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB2—kidney cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB2—kidney cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	1.85e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—JUN—kidney cancer	1.85e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	1.84e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MAPK1—kidney cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MAPK1—kidney cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MTOR—kidney cancer	1.83e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MTOR—kidney cancer	1.83e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—kidney cancer	1.81e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—kidney cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—kidney cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—kidney cancer	1.79e-06	1.71e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	1.79e-06	1.71e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—kidney cancer	1.78e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—kidney cancer	1.78e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.78e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	1.78e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1B—kidney cancer	1.77e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.77e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	1.77e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	1.76e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	1.76e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.76e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—kidney cancer	1.75e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.74e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.74e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—kidney cancer	1.74e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL2—kidney cancer	1.73e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—kidney cancer	1.73e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—kidney cancer	1.73e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—kidney cancer	1.72e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—kidney cancer	1.72e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1B—kidney cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1B—kidney cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK3—kidney cancer	1.71e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—POMC—kidney cancer	1.7e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—kidney cancer	1.7e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—kidney cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—kidney cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—JUN—kidney cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.68e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL2—kidney cancer	1.68e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL2—kidney cancer	1.68e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.68e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CTNNB1—kidney cancer	1.67e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.67e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.67e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.66e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—kidney cancer	1.66e-06	1.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.65e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.64e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—kidney cancer	1.64e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—kidney cancer	1.64e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—kidney cancer	1.64e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—kidney cancer	1.64e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—kidney cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—JUN—kidney cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—JUN—kidney cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—kidney cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—kidney cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—kidney cancer	1.63e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.62e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—kidney cancer	1.62e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CTNNB1—kidney cancer	1.62e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CTNNB1—kidney cancer	1.62e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	1.61e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—kidney cancer	1.6e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.6e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—kidney cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—kidney cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.58e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—kidney cancer	1.58e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—kidney cancer	1.58e-06	1.51e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.57e-06	1.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.57e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—kidney cancer	1.55e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—kidney cancer	1.55e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—kidney cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—kidney cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.5e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.5e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.49e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.48e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—kidney cancer	1.48e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.48e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.48e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—kidney cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.45e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—kidney cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—kidney cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK3—kidney cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—kidney cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—kidney cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.37e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—kidney cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—kidney cancer	1.36e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK3—kidney cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK3—kidney cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—kidney cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—kidney cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—kidney cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—kidney cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK1—kidney cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—kidney cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—kidney cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—kidney cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—POMC—kidney cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK1—kidney cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK1—kidney cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—kidney cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—kidney cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—kidney cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—kidney cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—kidney cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—kidney cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—kidney cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—kidney cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—kidney cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—kidney cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.05e-06	9.97e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.04e-06	9.95e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—kidney cancer	9.83e-07	9.38e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—kidney cancer	9.11e-07	8.69e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—kidney cancer	8.33e-07	7.95e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.43e-07	6.13e-06	CbGpPWpGaD
